Expanding Therapy With Long-Acting Antipsychotic Medication in Patients With Schizophrenia

被引：25
|
作者：
Carpenter, William T., Jr. [1 ]
Buchanan, Robert W. [1 ]
机构：
[1] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Baltimore, MD 21228 USA
来源：
JAMA PSYCHIATRY | 2015年 / 72卷 / 08期
关键词：
FLUPHENAZINE;
D O I：
10.1001/jamapsychiatry.2015.0485
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：745 / 746
页数：2
相关论文
共 50 条
  • [31] Antipsychotic long-acting injections
    O'Connor, Nick
    AUSTRALASIAN PSYCHIATRY, 2013, 21 (02) : 176 - 177
  • [32] Antipsychotic Long-acting Injections
    Livingston, Martin
    PSYCHIATRIC BULLETIN, 2011, 35 (11): : 438 - 439
  • [33] Long-Acting Antipsychotic Medications
    Baweja, Raman
    Sedky, Karim
    Lippmann, Steven
    CURRENT DRUG TARGETS, 2012, 13 (04) : 555 - 560
  • [34] The Challenge of Offering Long-Acting Antipsychotic Therapies: A Preliminary Discourse Analysis of Psychiatrist Recommendations for Injectable Therapy to Patients With Schizophrenia
    Weiden, Peter J.
    Roma, Rebecca S.
    Velligan, Dawn I.
    Alphs, Larry
    DiChiara, Matthew
    Davidson, Brad
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (06) : 684 - 690
  • [35] Risperidone long-acting therapy in stable patients with recently diagnosed schizophrenia
    Macfadden, Wayne
    Bossie, Cynthia A.
    Turkoz, Ibrahim
    Haskins, John Thomas
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2010, 25 (02) : 75 - 82
  • [36] Outcomes of patients with schizophrenia who discontinued long-acting injectable antipsychotic therapy due to adverse events: A chart review
    Kishi, Taro
    Sakuma, Kenji
    Okuya, Makoto
    Hatano, Masakazu
    Iwata, Nakao
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2021, 41 (03) : 422 - 425
  • [37] Use of a long-acting atypical antipsychotic in bipolar patients
    Singh, M.
    EUROPEAN PSYCHIATRY, 2008, 23 : S236 - S236
  • [38] Predictors of long-acting injectable antipsychotic prescription at discharge in patients with schizophrenia and other psychotic disorders
    Sahin, Olcay Senay
    Mursalova, Zhala
    Gadimov, Shahriyar
    Ucok, Alp
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (05) : 251 - 256
  • [39] Does a long-acting atypical antipsychotic offer a low risk of tardive dyskinesia in patients with schizophrenia?
    Chouinard, G
    Lasser, R
    Bossie, C
    Zhu, Y
    Gharabawi, G
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 81S - 82S
  • [40] Does a long-acting atypical antipsychotic offer a low risk of tardive dyskinesia in patients with schizophrenia?
    Chouinard, G
    Lasser, R
    Bossie, C
    Zhu, Y
    Gharabawi, G
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 277 - 277
12345